A number of guidelines are available for the management of congenital heart diseases (CHD) from infancy to adult life. However, these guidelines are for patients living in high-income countries. Separate guidelines, applicable to Indian children, are required when recommending an intervention for CHD, as often these patients present late in the course of the disease and may have coexisting morbidities and malnutrition. Guidelines emerged following expert deliberations at the National Consensus Meeting on Management of Congenital Heart Diseases in India, held on August 10 and 11, 2018, at the All India Institute of Medical Sciences. www.annalspc.com
Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 subsequent National Consensus Meeting, which was held in New Delhi after a gap of 10 years, in August 2018. In the intervening 10 years, a number of pediatric cardiac centers have been established, and overall, the numbers of interventions have increased by several folds. Considering the growing population of postoperative patients including those needing regular follow-up, we added guidelines and protocols for follow-up of these patients.
INTRODUCTION
Congenital heart diseases (CHDs) are the most common birth defects, responsible for nearly one-third of all congenital birth defects. [1] The birth prevalence of CHD is reported to be 8-12/1000 live births. [2, 3] One-fifth of these babies have critical heart disease requiring very early intervention. Advances in pediatric cardiology and cardiac surgery have made it possible to repair or palliate most of the CHDs including the complex ones. If access to screening, early diagnosis, and treatment is available, over 90% of patients born with CHD survive to adult life with good long-term outcome. [4] Most middle-and low-income countries lack such advanced level of care for children with CHD. Considering a birth prevalence as 9/1000, the estimated number of children born with CHD every year in India approximates 240,000, posing a tremendous challenge for the families, society, and health-care system. Approximately 10% of infant mortality in India may be accounted for, by CHDs.
JUSTIFICATION FOR DEVELOPING INDIAN GUIDELINES
Evidence-based recommendations for the management of CHD have been published by task force members from a number of national and international associations, but these are primarily meant for children born in high-income countries. Applicability of these guidelines to the Indian population with CHD is likely to be limited. Majority of patients with CHD are not diagnosed in antenatal period and often present late in the course of the disease. These patients are often underweight, malnourished, and have comorbidities such as recurrent infections and anemia. Many of late presenters have advanced level of pulmonary hypertension, ventricular dysfunction, hypoxia, polycythemia, etc. The outcome after surgery in such patients is expected to be suboptimal with long periods of mechanical ventilation and stay in intensive care. Modifications in the treatment protocol may be required for optimizing the outcomes. All these factors justify the need for separate guidelines for the management of CHD in India, including the timing of intervention.
A statement on "consensus on timing of intervention for common congenital heart disease" which originated from the Meeting of Working Group on Management of Congenital Heart Disease in India, was published in 2008. [5] This statement was revised and updated in the Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 3. To formulate the guidelines for the use of pacemakers in children.
GUIDELINES FOR INDIVIDUAL CONGENITAL HEART DEFECTS ATRIAL SEPTAL DEFECT
Background Atrial septal defect (ASD) is the second most common congenital heart defect with a prevalence of 56/100,000 live births. Higher estimates have been reported more recently, perhaps related to wide availability of echocardiography. [6] ASD is responsible for 15%-20% of all congenital heart defects. They are usually diagnosed incidentally in childhood due to a murmur. Symptoms may develop as age advances. Atrial arrhythmias tend to occur in those over 40 years of age. Spontaneous closure of the defect is rare if defect is >8 mm at birth and after 2-3 years of age. Very rarely, an ASD can enlarge on follow-up. [7, 8] 14% of patients with large ASD develop the serious complication of pulmonary vascular disease, usually between 20 and 40 years of age. [9] However, in a series from India, pulmonary vascular disease developed in the first decade in 7% of patients with secundum ASD. [10] Types of atrial septal defect i. Ostium secundum (~75%) ii. Ostium primum (15%-20%) iii. Sinus venosus (5%-10%) iv. Coronary sinus (<1%) Patent foramen ovale Echocardiographic detection of a small defect in fossa ovalis region with a flap with no evidence of right heart volume overload (dilatation of right atrium and right ventricle [RV] ). Patent foramen ovale is a normal finding in newborns.
Diagnostic workup i. Clinical assessment ii. X-ray chest: Right atrial enlargement, right ventricular enlargement, dilated main pulmonary artery segment, and increased pulmonary vasculature markings iii. Electrocardiogram (ECG): Signs of right ventricular volume overload, seen as incomplete right bundle branch block and right atrial enlargement. Crochetage sign (notched R wave in all inferior limb leads) may be seen in those with large left-to-right shunts. iv. Echocardiography: This is the key tool not only for the diagnosis of ASD, but also for determining its location and number, for the assessment of pulmonary artery pressure and pulmonary venous drainage, and for evaluating for suitability for device closure of the defect. Transesophageal echo may be required if transthoracic windows are suboptimal.
Transesophageal echo is often performed in the cardiac catheterization laboratory during device closure of ASD. v. Cardiac catheterization: It is mostly performed for device closure of the defect. A diagnostic catheterization is required in those with pulmonary hypertension and suspected pulmonary vascular disease.
Indication for closure An ASD with left to right shunt, associated with evidence of right ventricular volume overload without evidence of irreversible pulmonary vascular disease (Class I).
Indications for ASD closure remain the same, irrespective of the method of closure.
Contraindication for closure Severe pulmonary arterial hypertension or irreversible pulmonary vascular occlusive disease (Class III). Patients with borderline operability due to pulmonary vascular disease should be referred to a higher center for further evaluation.
Ideal age of closure
i. In an asymptomatic child: 2-4 years (Class I). For sinus venosus defect, surgery may be delayed to 4-5 years (Class IIa). ii. Symptomatic ASD in infancy (congestive heart failure and pulmonary artery hypertension): seen in about 8%-10% of cases. Early closure is recommended (Class I) after ruling out associated lesions (e.g., total anomalous pulmonary venous drainage, left ventricular inflow obstruction, and aortopulmonary window [APW] ). iii. If presenting beyond ideal age: Elective closure irrespective of age as long as there is left-to-right shunt with right heart volume overload and pulmonary vascular resistance (PVR) is within operable range (Class I). iv. Symptomatic sequel of paradoxical emboli such as stroke or recurrent transient ischemic attack due to transient right-to-left shunting at the atrial level (Class IIa). This complication is more likely with patent foramen ovale with or without atrial septal aneurysm.
Method of closure
Surgical: Established mode (Class I).
Device closure: More recent method, used for secundum ASDs only (Class I).
Device closure is not advised for secundum atrial septal defect (due to higher likelihood of complications) if: a. Antiplatelet agents: Aspirin (3-5 mg/kg/day) is given a day before or immediately after the procedure and then continued;
• Device ≤30 mm -Aspirin (3-5 mg/kg/day) is continued for total duration of 6 months.
• Device >30 mm -Aspirin (3-5 mg/kg/day) and clopidogrel (1.5-2 mg/kg/day) are given for 3 months followed by aspirin alone for 3 more months. b. Echocardiography: At discharge, 1 month, 6 months, 1 year, and then every 3-5 years. iii. Infective endocarditis (IE) prophylaxis is recommended for 6 months after device or surgical closure. However, all patients are advised to maintain good oro-dental hygiene after this period also.
ISOLATED VENTRICULAR SEPTAL DEFECT
Background Ventricular septal defect (VSD) is the most common congenital heart defect (excluding bicuspid aortic valve [BAV] ) and constitutes 20%-30% of all congenital heart defects. [6] The prevalence varies from 3 to 5/1000 live births. [11, 12] However, a much higher prevalence (50/1000 live births) is reported due to ease of detection of small muscular VSDs by echocardiography.
Clinical manifestations depend on the size of the defect and the pulmonary and systemic vascular resistances. About 10% of patients with large VSDs die in 1 st year, primarily due to congestive heart failure. [13] Rate of spontaneous closure depends on the size and location of the defect. Spontaneous closure is uncommon in large VSDs. Inlet and malaligned VSDs almost never close spontaneously. Muscular VSDs are more likely to close spontaneously, especially if they are not large. Decrease in size of VSD is seen in 25% of patients. Small VSDs have a >50% chance of spontaneous closure by 5 years of age and a >80% chance by adolescence. [14] Progressive right ventricular outflow tract obstruction (Gasul phenomenon) may develop in 13% and aortic regurgitation (AR) in 6% of patients. [15] In the historic series of Dr. Paul Wood, 52% of patients with large VSD developed irreversible pulmonary vascular disease with the onset in infancy in four-fifths of them. [16] The incidence of IE in patients with small VSD is 1.3 per 1000 patient-years. [17] Classification of ventricular septal defect i. Perimembranous: 80% ii. Outlet or subpulmonary (doubly committed): 5%-7% iii. Inlet: 5%-8% iv. Muscular: 5%-20%, these could be central (midmuscular), apical, marginal (anterior, septal-free wall area), or multiple, "Swiss cheese" type.
Classification according to the size of the defect
i. Small (restrictive) VSD: Diameter of the defect is less than one-third of the size of aortic orifice. Right ventricular and pulmonary artery pressure is normal, left-to-right shunt is <1.5:1 and left sided cardiac chambers are normal in size. ii. Moderate VSD (restrictive): Diameter of the defect is more than one-third but less than the size of aortic orifice. Right ventricular and pulmonary artery pressure varies from normal to two-thirds of systemic pressure, left-to-right shunt is >1.5:1 and left sided cardiac chambers are dilated. iii. Large VSD (nonrestrictive): Diameter of the defect is equal to or more than the size of aortic orifice. Right ventricular and pulmonary artery systolic pressures are systemic or near systemic. Degree of left-to-right shunt depends on PVR. The left-sided cardiac chambers are dilated when PVR is normal or mildly elevated.
Diagnostic workup
i. Clinical assessment ii. X-ray chest: The X-ray chest may be completely normal if the VSD is small. Cardiomegaly, increased pulmonary vascularity with prominent pulmonary artery segment is suggestive of significant left-to-right flow. The degree of cardiomegaly correlates well with degree of left-to-right shunting. Those with large VSD and significantly elevated PVR show absence of cardiomegaly, prominent pulmonary artery segment, dilated central pulmonary arteries, and decreased pulmonary vascularity in outer third of lung fields. iii. ECG: ECG may be normal in small VSD. Patients with significant left-to-right shunt show signs of left ventricular volume overload, left ventricular hypertrophy (tall R waves and tall peaked T waves in inferior and lateral leads with prominent q waves in V5-V6), and left atrial enlargement (broad notched P waves in lead I and II, with a broad deep P terminal force in lead V1 a. Poor growth/congestive heart failure not controlled with medications (furosemide/ spironolactone/enalapril ± digoxin): As soon as possible b. Controlled heart failure: By 6 months of age. IV. VSD with aortic cusp prolapse:
Any VSD with cusp prolapse and directly related AR that is more than trivial: Surgery whenever AR is detected.
All patients with VSD must be advised to maintain good oro-dental hygiene.
Contraindications for closure Severe pulmonary arterial hypertension with irreversible pulmonary vascular occlusive disease (Class III).
Patients with borderline operability due to pulmonary vascular disease should be referred to a higher center for further evaluation. The decision to operate or not should be made on an individual basis taking into account the total picture of the case including results of the investigations. 
Method of closure

Hybrid procedure (Class IIb)
It can be considered in infants with muscular VSDs where percutaneous approach is prohibitive due to sheath size. 
Recommendations for follow-up
ATRIOVENTRICULAR SEPTAL DEFECT
Background AV septal defects (AVSDs) account for 4%-5% of all congenital heart defects with estimated incidence of 0.19/1000 live births. [6] These lesions can be divided into partial and complete forms. Clinical manifestations and outcome of patients with AVSD depend on the size of VSD, degree of ventricular hypoplasia (if any), AV valve regurgitation, presence or absence of left ventricular outflow tract obstruction, and presence or absence of associated syndromes. Down syndrome is present in 50% of patients with AVSD. Conversely, about 40%-45% of children with Down syndrome have CHD, and AVSD accounts for almost half of these, mostly in its complete form. [18] Patients with Down syndrome tend to develop early and more severe form of pulmonary vascular disease with irreversible changes appearing as early as 6 months of age. [19] The presence of preoperative left AV valve regurgitation is associated with increased risk of surgery and need for reoperations on follow-up. Complete form of AVSD, if left untreated, has a survival of only 54% at 6 months and 35% at 12 months. [20] Partial form of AVSD has a better survival with 50% alive at 20 years of age. [21] Types of atrioventricular septal defects i. Complete AVSD: Large septal defect with an atrial component (ostium primum defect) and a ventricular component (inlet septal defect), common AV valve ring, and common AV valve. There may be incompetence of the right-and left-sided parts of the common AV valve. Complete form of AVSD is generally associated with large left-to-right shunt, pulmonary artery hypertension, and congestive heart failure. ii. Partial AVSD: These patients have separate annuli of right and left AV valve. There is a primum ASD. Cleft of the anterior leaflet of AV valve is common with variable degrees of regurgitation.
iii. significant pulmonary hypertension and suspected elevated PVR should be referred to a higher center for further evaluation to assess operability.
All patients with AVSD must be advised to maintain good oro-dental hygiene.
Contraindication for surgical repair AVSD with severe pulmonary arterial hypertension and irreversible pulmonary vascular occlusive disease (Class III).
Patients with borderline operability due to pulmonary vascular disease should be referred to a higher center for further evaluation. The decision to operate or not should be made on an individual basis taking into account the total picture of the case including results of the investigations.
Important determinants of long-term prognosis These include left AV valve stenosis/regurgitation (5%-10%), subaortic stenosis (5%), atrial arrhythmias, late-onset CHB, and issues related to Down syndrome (if present).
Recommendations for follow-up i. Lifelong follow-up is required.
ii. In patients with no significant residual abnormality, annual follow-up is required till 10 years of age followed by 2-3-yearly follow-up. The patient should undergo physical examination, ECG, and echocardiography at each visit, and a Holter monitor test may be required in select cases. iii. IE prophylaxis is recommended for 6 months after surgical closure. However, all patients are advised to maintain good oro-dental hygiene after this period also.
PATENT DUCTUS ARTERIOSUS
Background Patent ductus arteriosus (PDA) constitutes 5%-10% of all congenital heart defects with a prevalence of "symptomatic" PDA being 0.5/1000 live births. [6] Clinical manifestations depend on the diameter and length of PDA and the relative systemic and pulmonary vascular resistances. Frequency of patent ductus increases with decreasing gestational age and decreasing birth weight. Spontaneous closure rate of PDA in preterm neonates varies from 35% to 75% in the 1 st year of life. [22] Small PDAs in full-term neonates may close up to 3 months of age, whereas large PDAs are unlikely to close spontaneously. Rate of spontaneous closure of PDA after infancy is 0.6% per year. [23] In the historic Dr. Paul Wood's series, 79% of patients with large PDA had onset of Eisenmenger syndrome in infancy. [16] Classification according to the size of PDA All patients with PDA must be advised to maintain good oro-dental hygiene.
Contraindication for closure
PDA associated with severe pulmonary arterial hypertension with irreversible pulmonary vascular occlusive disease; and silent PDA (Class III). 
Method of closure
AORTOPULMONARY WINDOW
Background APW is a rare congenital cardiac malformation, comprising only 0.1% of all congenital heart defects. [6] In most patients with this anomaly, the defect is moderate to large. Associated anomalies occur in half of the cases and include interrupted aortic arch (most commonly type A interrupted aortic arch), origin of right pulmonary artery from the aorta, coarctation of aorta (CoA), right or left coronary artery origin from main pulmonary artery, tetralogy of Fallot [TOF], etc. [25] Clinical manifestations depend on the diameter of APW, the relative systemic and pulmonary vascular resistances, and associated lesions. Large APW is associated with very early development of advanced pulmonary vascular disease.
Types of aortopulmonary window [26] • 
Ideal age of closure
i. Uncontrolled heart failure: Surgical repair as soon as possible (Class I) ii. Controlled heart failure: Elective surgical repair by 3 months of age (Class I) iii. In patients with associated anomalies, single-stage repair of all defects is preferred (Class I). iv. Those presenting beyond 6 months of life with severe pulmonary hypertension and suspected elevated PVR should be referred to a higher center for further evaluation to assess operability.
All patients with APW must be advised to maintain good oro-dental hygiene.
Contraindication for closure
Severe pulmonary arterial hypertension with irreversible pulmonary vascular occlusive disease (Class III). Aspirin (3-5 mg/kg/day) is given a day before or immediately after procedure and continued for total duration of 6 months. iv. IE prophylaxis is recommended for 6 months after surgical or device closure. However, all patients are advised to maintain good oro-dental hygiene after this period also.
Method of closure
COARCTATION OF AORTA
Background Coarctation of Aorta (CoA) constitutes 6%-8% of all congenital heart defects with a prevalence of 0.24/1000 live births. [6] It is more common in males. It constitutes 15%-35% of cardiovascular malformations in children with Turner syndrome. [27, 28] BAV is the most common associated congenital anomaly seen in 80% of cases. [29] Clinical presentation depends on the age at presentation. Neonates and infants often present with congestive heart failure. There may be associated aortic arch hypoplasia. Older children and adults present with upper-limb arterial hypertension. The diagnosis may be incidental in older patients while they are being investigated for hypertension. Untreated patients who have survived infancy have a 25% survival at 46 years and 10% survival at 56 years. [30] The risk of residual hypertension and early atherosclerotic cardiovascular disease is increased with late repair. [31] The prevalence of residual hypertension is only 6% in repairs performed between 1 and 5 years of age in comparison with 30%-50% in patients repaired at an older age. [32] Diagnostic workup i. Clinical assessment: Weak and delayed femoral pulses in comparison with brachial/radial pulse are the key to the diagnosis. The diagnosis may be missed in neonates due to a PDA. Measuring blood pressure in all four limbs shows upper-limb hypertension and is a useful guide to the gradient across the CoA segment. ii. X-ray chest: Can be normal in asymptomatic infants and young children. Symptomatic neonates show pulmonary venous congestion with moderate-to-severe cardiomegaly, mainly due to dilation of the RV and the right and left atria. In children and young adults, heart size is normal or only mildly enlarged. Pulmonary vascular markings are normal unless there is an associated left-to-right shunt. The combination of a dilated left subclavian artery proximal to the coarctation and a dilated aorta distal to the coarctation produce a figure of 3 silhouette on the X-ray. Notching of the ribs is a classic radiologic sign caused by collateral flow through dilated, pulsatile posterior intercostal arteries. Rib notching seldom appears before 5-6 years of age. Typical coarctation distal to the left subclavian artery results in bilateral notching of the posterior aspects of third to eighth ribs. iii. ECG: Right-axis deviation with right ventricular hypertrophy is the typical finding in symptomatic neonates and infants. 
Ideal age for intervention
i. With left ventricular dysfunction/congestive heart failure or severe upper-limb hypertension (for age): Immediate intervention (Class I) ii. Normal left ventricular function, no congestive heart failure, and mild upper-limb hypertension: Intervention beyond 3-6 months of age (Class I) iii. No hypertension, no heart failure, normal ventricular function: Intervention at 1-2 years of age (Class I) iv. In patients with significant CoA associated with a sizable VSD, both defects should be repaired in a single stage (Class I).
Mode of intervention
i. Neonatal presentation: Surgery (Class I). Aortic arch hypoplasia, if associated, should also be repaired. ii. Critically ill neonates who are considered high risk for surgery (shock-like syndrome and severe left ventricular dysfunction): Balloon angioplasty to tide over the crisis (Class IIa) iii. Infants with native coarctation: Surgery (Class I) or balloon angioplasty (Class IIa) iv. I n f a n t s w i t h r e c o a r c t a t i o n : B a l l o o n angioplasty (Class I) v. Children <25 kg with native coarctation: Balloon angioplasty (Class I) or surgery (Class IIa) vi. Children <25 kg with recoarctation: Balloon angioplasty ± stenting (Class I) vii. Children >25 kg and adults with native coarctation:
Catheter-based stenting (Class IIa) viii. Children >25 kg and adults with recoarctation:
Catheter-based stenting (Class I) ix. Elective endovascular stenting of aorta is co nt r aindicated in childr en <10 y ear s o f age (Class III).
Indications of using a covered stent (provided the anatomy is suitable)
i. Native coarctation where risk of rupture of aorta is high a. BAV with ascending aorta dilation b. Nearly atretic isthmus (<3 mm diameter) c. Turner syndrome d. Age >60 years e. Marfan syndrome ii. Recoarctation with aneurysm or pseudoaneurysm at the site of CoA.
All patients with CoA must be advised to maintain good oro-dental hygiene.
Important determinants of long-term prognosis
Residual or recurring coarctation, status of aortic valve (if bicuspid), aneurysms of the ascending aorta or aneurysm at the intervention site, premature coronary artery disease, and berry aneurysms of the circle of Willis. iii. Clinical assessment should include measuring u p p e r -a n d l o w e r -l i m b b l o o d p r e s s u r e . Echocardiography to be done at each follow-up to exclude any residual issues and to assess for other abnormalities, such as BAV. iv. Beyond 5 years of age, echo alone may not be sufficient for evaluation. cMRI or CTA is recommended 3-5 yearly or earlier. cMRI is preferable in postsurgical and postballoon angioplasty patients while CTA is preferred after endovascular stenting. v. Beta-blockers are the preferred drugs for control of hypertension. vi. IE prophylaxis is needed for 6 months after surgery and intervention. However, all patients are advised to maintain good oro-dental hygiene after this period also.
Follow-up recommendations
AORTIC STENOSIS
Background Aortic stenosis (AS) is most often due to stenosis of the aortic valve (80%-85%), but can also be due to obstruction below the valve (subvalvular, 15%, mostly due to discrete membrane) or above the valve (supravalvular, least common). AS is more common in males. The aortic valve can be unicuspid or bicuspid in patients with valvular AS. Patients with unicuspid aortic valve present commonly in neonatal period with critical stenosis, whereas patients with bicuspid valve present more commonly during childhood. BAV has been identified in 1% of the general population; however, the incidence of valvular AS is 0.2-0.4/1000 live births. [6] BAV occurs in 9% of asymptomatic first-degree relatives of patients with BAV. [33] Severity of AS usually progresses in 89% of children under 2 years, and 61% of children over 2 years show progression. [34] Ascending aorta dilation (aortopathy), as defined by a Z score >2, has been seen in 74% of children with BAV and the dilatation tends to worsen over time. [35] The incidence of endocarditis in AS is 2.7/1000 patient-years. [36] Untreated aortic valve stenosis presenting in infancy carries a mortality rate of 23%; mortality decreases after that (1.2% per year for the first two decades of life). [37] The risk of sudden death is 0.4%-0.9% per year. Supravalvular stenosis is often associated with Williams-Beuren syndrome.
Diagnostic workup
i. Clinical assessment ii. X-ray chest: Normal-sized heart with poststenotic dilation of ascending aorta is seen when obstruction is at valve level. All patients with AS must be advised to maintain good oro-dental hygiene.
Important determinants of long-term prognosis
Residual or recurring stenosis, progressive aortic dilation, complications related to prosthetic valve function, such as stuck valve leaflet, paravalvular leak, patient-prosthesis mismatch, and pannus formation. Dysfunction of RV-to-pulmonary artery conduit in those undergoing Ross operation. 
Recommendations for follow-up
PULMONIC STENOSIS
Background Pulmonary stenosis (PS) is a common congenital heart defect, occurring either as an isolated lesion or in association with other CHD. The prevalence of isolated PS is 7/10,000 and is found in 8%-10% of all patients with CHD. [6, 11] The obstruction is at the valve level in 80% to 90% of patients, and the rest have obstruction below or above the pulmonary valve. Isolated subvalvular PS is uncommon, and it is generally associated with a VSD.
The pulmonary valve is dysplastic in 10%-20% of all valvular PS patients. [38] PS may be associated with Noonan, Holt-Oram, or LEOPARD syndrome. Older patients with valvular PS are often asymptomatic, and the diagnosis is made on incidental detection of murmur on routine examination. Occasionally, however, they present in heart failure due to right ventricular dysfunction secondary to severe PS. Neonates and infants with critical PS may present with cyanosis due to right-to-left shunt across an ASD. PS may remain stable, progress, or rarely improve. Progression is more likely in infants than in older children or adults with mild PS. [39, 40] The natural history of patients with valvular PS is excellent with 1-year, 2-year, and 15-year actuarial survival rate of 97%, 96%, and 94%, respectively. [41] Diagnostic workup i. Clinical assessment: Phasic ejection click, a hallmark feature of valvular PS may be absent in dysplastic pulmonary valve.
ii. 
Recommendations for follow-up
i. All patients with PS require lifelong follow-up.
ii. Clinical assessment, ECG, and echo are required at each visit, the interval depending on the severity of stenosis. iii. Infants with mild PS in whom intervention is not indicated should be followed 3 monthly until 1 year of age. Thereafter, they should be followed every 1-2 years till 10 years of age and later every 3-5 years. Those with more than mild stenosis (native or after balloon dilation) may be followed every year beyond the infancy period. iv. IE prophylaxis is recommended in patients with a prosthetic valve. However, all patients with PS are advised to maintain good oro-dental hygiene.
TETRALOGY OF FALLOT
Background TOF is the most common cyanotic congenital heart disease with a prevalence of 0.4/1000 live births constituting about 5% of all congenital heart defects. [11] The clinical signs and symptoms seen in infants generally vary in accordance with the degree of right ventricular outflow tract obstruction. Almost two-thirds of newborns with TOF are acyanotic at birth, but by 6 months of age, over half of them have cyanosis at rest. [42] This occurs because of worsening infundibular stenosis which increases right-to-left shunting across the VSD. Intermittent hypercyanotic spells are one of the defining features of TOF. Peak incidence of these episodes occurs Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 between the 2 nd and 6 th months of life, and these become infrequent after 2 years of age. [43] Patients with untreated TOF have an estimated 1-year, 3-year, and 10-year survival of 66%, 49%, and 24%, respectively. [44] Diagnostic workup i. Clinical assessment: Degree of cyanosis is the most important aspect of clinical evaluation. ii. Pulse oximetry: Measuring oxygen saturation by pulse oximeter is recommended at each follow-up examination. Anemia may undermine the severity of clinical cyanosis. iii. ECG: Typical ECG shows right-axis deviation, right ventricular hypertrophy, and an early QRS transition with abrupt change from an R wave in lead V1 to an rS pattern in lead V2. The presence and depth of Q waves and the amplitude of R waves in leads V5-6 reflects the magnitude of pulmonary blood flow and left ventricular filling. Surgical repair of TOF often disrupts the electrical conduction pathways and >90% of patients exhibit right bundle branch block after surgical repair. iv. X-ray chest: Normal heart size with an upturned apex ("boot-shaped" heart due to right ventricular hypertrophy), deficiency of the main pulmonary artery segment ("pulmonary bay" seen as a concavity in the upper left cardiac border), and reduced pulmonary vascularity are the cardinal features.
Other findings include dilated ascending aorta and right aortic arch (20%-30% 
Medical management (Class I)
i. Maintain Hb >14 g/dL (using oral iron or blood transfusion) ii. Oral propranolol to be given in highest tolerated doses (usual dose is 1-4 mg/kg/day in 2-3 divided doses) iii. Prostaglandin infusion for neonates with significant cyanosis. 
Management of cyanotic spell
Important determinants of long-term prognosis
These include pulmonary regurgitation (almost invariably present after repair), residual lesions (VSD, right ventricular outflow tract obstruction, and pulmonary artery branch stenosis), right ventricular outflow tract aneurysms, aortic root dilatation, functional abnormalities (right ventricular volume and pressure overload), ventricular dysfunction, conduction abnormalities, and arrhythmias.
Recommendations for follow-up
i. All patients with TOF require lifelong follow-up in view of the above-listed postoperative issues. ii. Asymptomatic patients with no residual lesion but with free pulmonary regurgitation, not requiring intervention, should be followed up 1-2 yearly. iii. Clinical assessment, ECG, and echocardiogram are to be done at each visit. Holter monitoring is indicated in patients suspected of having arrhythmia. iv. Cardiac catheterization should be performed if any residual lesion is suspected. It may also be required for a percutaneous intervention such as stenting of pulmonary artery branch for stenosis.
v. cMRI is an important investigation for follow-up of these patients. In asymptomatic patients, baseline study should be performed 10 years after surgery with periodic follow-up, with frequency of repeat imaging determined by anatomic and physiological findings. Right ventricular volumes and function assessment by cMRI are an important indicator for pulmonary valve replacement. vi. Those who have undergone a prosthetic pulmonary valve replacement require periodic monitoring of anticoagulation (INR levels). However, bioprosthetic valves are more commonly used for pulmonary valve replacement and these patients do not require long-term anticoagulation. vii. IE prophylaxis is indicated in noncorrected patients, patients after surgical repair for 6 months, and patients with percutaneous or surgical pulmonary valve replacement. However, all patients with TOF are advised to maintain good oro-dental hygiene even after 6 months of surgical repair.
Indications for pulmonary valve replacement [45] i. Symptomatic patients with symptoms attributed to severe right ventricular volume overload with moderate or severe pulmonary regurgitation (Class I). 
VENTRICULAR SEPTAL DEFECT WITH PULMONARY ATRESIA
Background VSD with pulmonary atresia (VSD-PAt) is the most severe form of TOF. In the Bohemia survival study, a prevalence of 0.07 per 1000 live births was observed for VSD-PAt, accounting for 20% of all forms of TOF. [46] About 20% of cases are associated with a syndrome/genetic defect. [47] This CHD usually presents in the neonatal period with cyanosis due to right-to-left shunt at ventricular level. The degree of cyanosis depends on the magnitude of pulmonary blood flow, which in turn, depends on the size of PDA and/or the number and size of aortopulmonary Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 collaterals. Closure of the ductus in the early neonatal period can be lethal due to acute severe cyanosis. After the neonatal period, cyanosis gradually increases. [6] Rarely, however, patients may present in congestive heart failure due to multiple aortopulmonary collaterals (MAPCAs) or a large PDA. [48] Untreated patients with VSD-PAt have a very dismal outcome with the 1-year and 10-year survival being 50% and 8%, respectively. [44] Anatomical types VSD-PAt is a complex disease with varying anatomy, especially related to pulmonary artery branches and sources of pulmonary arterial blood supply. The detailed anatomy must be defined in each case to plan management. For the sake of simplicity, VSD-PAt is classified into four types.
• Type A -Short-segment valvular atresia, pulmonary arteries confluent, and good sized, supplied by a PDA • Type B -Long-segment pulmonary atresia with absent main pulmonary artery. Branch pulmonary arteries confluent and good sized, supplied by a PDA • Type C -Long-segment pulmonary atresia with absent main pulmonary artery. Branch pulmonary arteries confluent, but pulmonary blood flow dependent predominantly on MAPCAs • Type D -Long-segment pulmonary atresia with absent main pulmonary artery. Nonconfluent branch pulmonary arteries with MAPCA-dependent pulmonary blood flow.
Diagnostic workup
i. Clinical assessment.
ii. Pulse oximetry: Measuring oxygen saturation by pulse oximeter is recommended. Anemia may undermine the severity of clinical cyanosis. iii. ECG: The findings are same as in TOF; right-axis deviation with right ventricular hypertrophy.
Patients with increased pulmonary blood flow may have biventricular hypertrophy and left atrial enlargement. iv. X-ray chest: The absence of cardiomegaly and pulmonary oligemia as seen in classical TOF. In patients with predominant MAPCA-dependent pulmonary blood flow, pulmonary vascular markings usually have a heterogeneous reticular appearance. The right-sided aortic arch is more common in patients with VSD-PAt (26%-50%) than in those with TOF (20%-30%). v. Echocardiography: It is a vital tool for the diagnosis; however, it may not delineate the distal pulmonary arterial tree or the sources of pulmonary arterial supply. Hence, additional imaging in the form of cardiac catheterization, CTA/cMRI, or a combination of these is essential for planning definitive repair. vi. Laboratory investigation: Hb/PCV must be measured in every child because cyanotic patients require a Either CTA or cMRI is recommended for all patients planned for a repair (Class I). The number of segments of the lung which are supplied by native pulmonary arteries is very well defined by CTA. ix. cMRI: It provides the same information as CTA without exposure to radiation, but is more time-consuming and is less widely available. It is of particular benefit in the evaluation of operated patients with conduit to monitor the conduit function, assessing right ventricular function and volumes, and deciding timing for further interventions.
Medical management (Class I)
i. Neonates presenting with significant cyanosis due to closing ductus should be started on prostaglandin E1 (PGE1) infusion for preoperative stabilization. Lowest maintenance dose should be used once PDA is open. ii. Maintain Hb >14 g/dL (using oral iron or blood transfusion). iii. Management of cyanotic spell is the same as described in TOF. iv. Propranolol to be given in highest tolerated doses (usual dose is 1-4 mg/kg/day in 2-3 divided doses).
Indications and timing of intervention
Management depends on the type of VSD-PAt, the institutional experience, and the clinical presentation. In general, this lesion requires a multistage management.
Patients with Type C and D have a more complex anatomy and are best referred to a specialized center for further treatment.
• Type A (short-segment VSD-PAt with PDA) i. Presentation with significant cyanosis at < 1 year of age: Aortopulmonary shunt (Class I) or PDA stenting (Class IIa) depending on the institutional preference and feasibility. Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019
ii. After 1 st intervention or those presenting at ≥1 year of age: Total correction at about 1 year of age, since a RV-to-pulmonary artery (PA) conduit is not required (Class I).
• Type B (long-segment pulmonary atresia with PDA): i. Presentation with significant cyanosis at <1 year of age: Aortopulmonary shunt (Class I) or PDA stenting (Class IIa) depending on the institutional preference and feasibility. ii. After 1 st intervention or in those presenting at ≥1 year of age (Class I): a. Optimal pulmonary blood flow with good-sized PAs -Total repair with RV-PA conduit at 3-4 years b. Suboptimal pulmonary blood flow with small PAs -additional shunt followed by total repair with RV-PA conduit at 3-4 years c. Increased pulmonary blood flow with large PAs -total repair with RV-PA conduit by 1 year 
Some important considerations
• MAPCAs >2 mm in size are suitable for unifocalization.
• The decision regarding type of surgery is also influenced by the number of segments of lung that are supplied by native PAs and/or MAPCAs and, therefore, can be recruited.
• PDA stenting should not be done in the presence of branch pulmonary artery stenosis.
• Additional procedures which may be required in select cases include embolization of aortopulmonary collaterals (only if these lung segments have dual supply), stenting of MAPCAs, and balloon dilatation with or without stenting of branch pulmonary arteries.
Important determinants of long-term prognosis
These include conduit obstruction, degeneration, pulmonary artery branch stenosis, residual VSD, aortic root dilatation, functional abnormalities (right ventricular volume and pressure overload), ventricular dysfunction, conduction abnormalities, and arrhythmias. Patients who have undergone palliative procedures continue to have cyanosis and may develop complications due to right-to-left shunting.
Recommendations for follow-up
i. All patients with VSD-PAt require lifelong follow-up.
ii. Annual follow-up in those with no residual lesion.
iii. Palliated patients need to be seen more frequently if their oxygen saturation is low and to decide for the next intervention. iv. Clinical assessment, ECG, and echocardiogram are required; the interval depending on the nature of repair, residual or additional lesions, symptoms, and functional status. Holter monitoring should be done every 2-3 years even if no arrhythmia is suspected. v. cMRI is an important investigation for follow-up of these patients to determine the timing of conduit revision and pulmonary valve replacement. vi. Patients on warfarin, who have undergone a mechanical valve replacement, require periodic monitoring of anticoagulation (INR levels). vii. IE prophylaxis is indicated in noncorrected or palliated patients with cyanosis, patients after surgical repair for 6 months, and patients with conduits and pulmonary valve replacement. All patients are advised to maintain good oro-dental hygiene even after 6 months of surgical repair.
Indications for pulmonary valve replacement are same as in tetralogy of Fallot [45] Indications for conduit replacement [49] i. Symptomatic patients with right ventricular pressure by Doppler >80 mmHg and/or moderate-to-severe pulmonary regurgitation (Class I) 
TRANSPOSITION OF GREAT ARTERIES
Background Transposition of great arteries (TGA) is the most common cyanotic CHD at birth, accounting for approximately 5% of all CHDs. Its prevalence is 2-3/10,000 live births. [6] Boys are affected two to three times more as compared to girls. This anomaly is reported to be more common in infants born to mothers with diabetes, poor nutrition, or history of alcohol intake. [50, 51] In 70% of cases, there is no associated defect apart from ASD, PDA, or insignificant VSD; these cases are labeled as having simple TGA. Association of TGA with other defects such as large VSD and left ventricular outflow tract obstruction or coarctation is referred to as complex TGA. [52] It is a serious disease and most patients with TGA present very early in life, within few days or weeks after birth. The average life expectancy for an untreated newborn is 0.65 years, with mortality rate at 1 year being close to 90%. [53] With the advent of improved surgical techniques and postoperative care, long-term survival is > 90% with very low reintervention rates. [54] The best surgical option for patients with TGA is an arterial switch operation (ASO) where both arteries are switched so that ventriculoarterial concordance is achieved. However, ASO should be performed early, preferably within 3-4 weeks of life, before the left ventricular mass and volume regresses secondary to fall of PVR after birth. Regression of the left ventricle is accelerated in those with a nonrestrictive ASD. On the other hand, left ventricle does not regress in those associated with a significant sized VSD and/or PDA or left ventricular outflow tract obstruction as it faces elevated pressures.
Diagnostic workup
i. Clinical assessment: In simple TGA, cyanosis is the dominant feature; no heart murmur is audible in most cases. Those with large VSD and/or PDA present with features of heart failure. Weak femoral pulses indicate associated CoA. ii. Pulse oximetry and blood gases measurement:
Oxygen saturation should be measured in the right arm (preductal), because lower-limb saturation may be higher. In critically ill newborns, arterial (or venous) partial pressure of oxygen should be measured to assess degree of hypoxemia, lactic acidosis, and circulatory failure. iii. ECG: It shows right-axis deviation and right ventricular hypertrophy, which, however, may be normal for a newborn. Those with large VSD may show good left ventricular forces in addition. iv. X-ray chest: It can be completely normal or may have narrow pedicle with cardiomegaly (egg-on-side appearance) and increased pulmonary blood flow. 
v. Echocardiography: Key diagnostic imaging tool. It shows the following features: a. A t r i o v e n t r i c u l a r c o n c o r d a n c e w i t
Indications and timing of surgery
Important determinants of long-term prognosis
Long-term prognosis after surgery depends on the type of surgery performed. Early ASO patients fare well on long term. Attention should be paid to specific issues such as residual defects, coronary insufficiency with resultant myocardial ischemia/ventricular dysfunction, supravalvular obstruction of outflow tracts, neoaortic valve regurgitation, neoaortic root dilatation, arrhythmias, residual pulmonary hypertension, and recurring or late pulmonary hypertension. Specific issues after atrial switch operation include atrial arrhythmias, baffle leaks and obstructions, and development of right ventricular dysfunction.
Recommendations for follow-up
i. All patients need lifelong follow-up. Follow-up intervals depend on age, type of surgery, and residual findings. ii. In operated patients with no residual defects:
Follow-up visits should be at 1, 3, and 6 months after surgery, yearly after that till onset of adult life, and every 2-3 years thereafter. iii. Follow-up visits should include clinical assessment, ECG, and echocardiography. iv. Holter monitoring when suspecting arrhythmias and myocardial ischemia. Frequent Holter monitoring may be required following atrial switch operation. v. CTA or cMRI for coronary evaluation: Should be done at least once at 5-10 years of age. Earlier and more frequent evaluation of coronary arteries may be done in cases who had intramural coronary artery or difficult coronary transfer at the time of surgery. vi. IE prophylaxis is recommended in patients with cyanosis; for 6 months after definitive surgery; and in cases with conduits or other prosthetic material. However, all patients are advised to maintain good oro-dental hygiene even after 6 months of definitive surgery.
DOUBLE-OUTLET RIGHT VENTRICLE
Background Double-outlet RV (DORV) is a condition in which both great arteries are connected completely or predominantly to the RV. By definition, at least more than half of both arteries should arise from the RV. [56, 57] The VSD is the only outlet for left ventricle. The VSD could be subaortic (60%-65%), subpulmonary (20%-25%), doubly committed (3%-5%), or remote (noncommitted, 5%). [58] DORV may be associated with a number of cardiac anomalies including PS and CoA. The prevalence of DORV is 0.6/10,000 live births, and it constitutes <1% of all congenital heart defects. [6] The clinical presentation is variable and depends on the location of VSD, presence or absence of obstruction to pulmonary blood flow, and associated cardiac anomalies. [11] Clinical presentation of DORV can be divided into three types: i. TOF-like presentation: When the VSD is subaortic and there is obstruction to pulmonary outflow, the presentation is with progressive cyanosis and is indistinguishable from classic TOF. ii. VSD-like presentation: DORV with a large VSD in subaortic location presents with features of heart failure in infancy and mild cyanosis may be present. iii. TGA-like presentation: The VSD is subpulmonary in location and the great arteries are malposed (TaussigBing anomaly). There may be associated coarctation in some cases. Such patients present very early in life with cyanosis and heart failure. 
Indication and timing of surgery
Surgery is indicated for all patients with DORV, except in those with irreversible pulmonary vascular disease.
PGE1 infusion should be started in neonates presenting with duct-dependent pulmonary atresia or severe obstruction to pulmonary outflow.
Timing and type of surgery depends on double-outlet of right ventricle variant (Class I). i. DORV with subaortic VSD and PS (TOF-type DORV): a. P r e s e n t i n g w i t h s i g n i f i c a n t c y a n o s i s at <3-4 months: Aortopulmonary shunt. b. P r e s e n t i n g w i t h s i g n i f i c a n t c y a n o s i s at >3- 
Important determinants of long-term prognosis
The determinants of outcome vary with the anatomical variant and type of surgical correction. Important issues in operated patients include residual lesions, pulmonary valve incompetence, and arrhythmias. Those with RV-to-pulmonary artery conduits develop conduit stenosis and degeneration. Patients who have undergone an ASO may have residual pulmonary hypertension, coronary insufficiency, resultant myocardial ischemia/ ventricular dysfunction, supravalvular obstruction of both outflow tracts, neoaortic valve regurgitation, neoaortic root dilatation, and arrhythmias.
Recommendations for follow-up
i. All patients need lifelong follow-up; frequency to be individualized depending on the type of surgery, presence or absence of residual lesions, and functional status. ii. If no residual defect after surgery: Annual follow-up till adult life, then every 2 years. iii. Follow-up visits should include clinical assessment, ECG, and echocardiography. iv. Holter monitoring every 2-3 years after the age of 5 years. v. In post-ASO patients, coronary evaluation should be done by CTA or cMRI, at least once after the age of 5 years even if patient is asymptomatic. vi. IE prophylaxis is recommended in patients with cyanosis and in cases with conduits or other prosthetic material in the heart. Prophylaxis is also required for 6 months after definitive surgery. However, all patients with DORV are advised to maintain good oro-dental hygiene even after 6 months of definitive surgery.
CONGENITALLY CORRECTED TRANSPOSITION OF GREAT ARTERIES Background
Congenitally corrected TGA (ccTGA) is a congenital heart defect characterized by atrioventricular and ventriculoarterial discordance. This double discordance results in physiologically corrected circulation, as the great arteries receive appropriate blood. ccTGA occurs due to abnormal looping of the primitive cardiac tube to the left instead of to the right. ccTGA is a rare condition occurring in 0.3/10,000 live births and constitutes 0.5% of all congenital heart defects. [6] Although the physiology is corrected, anatomy is not, and morphologic RV supports systemic arterial circulation. In over 90% of cases, ccTGA is accompanied by other cardiac lesions: VSDs in 80%, PS (outflow obstruction to morphologic left ventricle) in 30%-50%, abnormalities of the conduction system in 15%-50%, ASD in 12%, and tricuspid valve abnormalities (as detected at autopsy) in 90%. [59] Mismatch between visceral situs and cardiac position is common, with dextrocardia/mesocardia in one-fourth of patients. The age of presentation is variable, and the presentation is determined by the associated anomalies.
Patients present with heart failure if a large VSD is present and as TOF physiology if large VSD is associated with significant PS. The associated anomalies affect the natural history of ccTGA. Approximately 10% are born with complete heart block (CHB). In the rest, the risk of developing CHB is 2% per year and about 30% develop CHB by adulthood. [60] The function of the RV deteriorates after the second decade even in those without any associated anomaly. [61] Diagnostic workup i. Clinical assessment: Features of heart failure, cyanosis, bradycardia, and systolic murmur of tricuspid regurgitation. ii. Pulse oximetry: For measuring arterial saturation in cyanosed patients. iii. ECG: In cases with situs solitus, the P wave axis is normal and q waves are present in the right precordial leads and absent in the left precordial leads. There may be evidence of CHB and rarely preexcitation pattern may be seen. iv. X-ray chest: Useful for the assessment of visceral situs and cardiac position. Cardiomegaly with pulmonary plethora suggests associated large VSD. Sometimes, an L-posed aorta produces a bulge on the upper left cardiac border. v. Echocardiography: Main imaging tool for determining the situs and cardiac position, atrioventricular and ventriculoarterial discordance, relationship of great arteries (aorta anterior and to left of pulmonary artery in situs solitus cases), and associated anomalies. Echocardiography is also very useful for the diagnosis of Ebstein's malformation of left-sided morphologic tricuspid valve, quantification of tricuspid regurgitation and for the assessment of right ventricular function. Older patients may require a transesophageal echo for complete evaluation. vi. Cardiac catheterization: Generally not required for making the diagnosis. It may have to be performed for demonstrating coronary anatomy or for the measurement of pulmonary artery pressure and PVR in those with large left-to-right shunts. vii. cMRI: In adults, diagnostic imaging alone with echo could be inconclusive; cMRI can provide the required information. It is very accurate for Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 evaluating ventricular volume, mass, and function, especially for the systemic RV and for the assessment of coronaries. cMRI is often utilized in follow-up of operated patients after a double-switch operation, for evaluating intra-atrial baffles. viii. Electrophysiological testing: May be required in selected patients, who have arrhythmia/blocks. ix. Exercise test: May be performed in a select group of patients to detect early right ventricular dysfunction.
Indications and timing of surgery [62, 63] The indications and timing of surgery in ccTGA depend on the presence and type of associated anomalies.
General recommendations i. Tricuspid valve (systemic AV valve) surgery for severe regurgitation should be considered before systemic ventricular failure (ejection fraction < 45%) sets in (Class IIa). ii. Anatomic repair (double-switch operation-atrial switch plus arterial switch or Rastelli) may be considered when left ventricle is functioning at systemic pressure and when such surgery is feasible (Class IIa).
Indications and timing for specific groups of congenitally corrected transposition of great arteries i. No associated anomalies: Medical follow-up to look for any development of tricuspid regurgitation or right ventricular dysfunction (Class I). Neonatal double-switch operation may be considered (Class IIb). ii. Associated with large VSD: a. <3 months: Pulmonary artery banding followed later by double-switch operation (atrial plus arterial switch) (Class I). b. >6 months: Double switch (atrial plus arterial switch), provided that the patient has not developed irreversible pulmonary vascular disease (Class I). c. 3-6 months: Pulmonary artery banding followed by double-switch operation or direct double-switch operation depending on institutional policy (Class IIa). 
Important determinants of long-term prognosis
These include right ventricular function, severity of left-sided systemic tricuspid regurgitation, arrhythmias, and cyanosis. Specific issues for operated patients include baffle problems, bradyarrhythmias, tricuspid regurgitation, and issues related to the type of operation done, such as atrial switch, Rastelli procedure, and/or ASO.
Recommendations for follow-up
i. All patients with ccTGA require lifelong follow-up, usually every year. ii. Clinical assessment, ECG, and echocardiography should be done at each visit. iii. Additional imaging may be required for better delineation of anatomy and function in adult patients, best done with cMRI. iv. Holter monitoring, exercise test, and electrophysiological study may be indicated in select patients. v. IE prophylaxis is recommended for all patients with cyanosis and in cases with conduits or other prosthetic material in the heart. It is also advised for 6 months after a definitive surgery. However, all patients with ccTGA are advised to maintain good oro-dental hygiene.
UNIVENTRICULAR HEARTS (SINGLE VENTRICLES)
Background Univentricular hearts are defined as the presence of one ventricle instead of two, or the second ventricle is rudimentary without an inlet portion. The main ventricle may be of left (more common) or right ventricular morphology or, in rare cases, indeterminate. The classical examples include double-inlet left ventricle, tricuspid atresia, and hypoplastic left heart syndrome. This term also includes a number of congenital heart defects where two-ventricle (or biventricular) repair is not possible. The examples include unbalanced AVSD, double-outlet RV with a nonroutable VSD, straddling of an AV valve, or a very large/multiple VSDs, not amenable to closure. These defects are often grouped together as "functional univentricular" heart, because the management is on the lines of single ventricle. [64] The prevalence is 2.3/10,000 live births, corresponding to 2.8% of all congenital heart defects. [11, 65] Heterotaxy syndrome may be associated in some cases. The single ventricle supports both the systemic and pulmonary circulations. The clinical presentation depends on the ratio of pulmonary-to-systemic blood flow. Infants with unrestricted pulmonary blood flow present with predominant heart failure and mild cyanosis and those with obstruction to pulmonary blood flow have dominant cyanosis and no heart failure. Rarely, there could be a balanced circulation. [6] Diagnostic workup i. Clinical assessment: Helps classify the univentricular heart into increased or restricted pulmonary blood flow group. ii. ECG: It is not specific and different types of abnormalities are described. It has no specific role, but may detect associated prexcitation, blocks, and atrial arrhythmias. iii. X-ray chest: Cardiomegaly with pulmonary plethora if the pulmonary flow is unrestricted. Normal-sized heart with oligemic lung fields in those with restricted pulmonary blood flow. iv. Pulse oximetry: For quantifying cyanosis which may
give an estimate of pulmonary blood flow restriction. v. Echocardiography: Key diagnostic tool. Useful to define anatomy, function of the single ventricle, any restriction to pulmonary blood flow, presence of atrioventricular valve atresia/ regurgitation, assess aortic arch, subaortic obstruction, restrictive atrial septal defect, etc. vi. Cardiac catheterization: Usually not required for diagnosis. Indications include: a. For assessing PVR in patients with unrestricted pulmonary blood flow, presenting beyond 6 months of life. b. Patients with unrestricted pulmonary blood flow having an arterial saturation of <90%.
c. Before bidirectional Glenn procedure, if the patient has undergone a pulmonary artery banding, or if any degree of pulmonary hypertension is suspected. d. Before total cavopulmonary connection (Fontan) in all patients. e. For interventions such as stenting of ductus arteriosus and occlusion of aortopulmonary collaterals. f. Operated patients: Failing Fontan, branch pulmonary artery stenting, fenestration closure or fenestration creation, occlusion of venovenous collaterals. vii. CTA: Required to define associated lesions such as total anomalous pulmonary venous connection (TAPVC), pulmonary vein stenosis, and systemic venous abnormalities. CTA is frequently done before bidirectional Glenn procedure to assess the adequacy of size of branch pulmonary arteries and to look for any evidence of obstruction or narrowing as that will need repair at the time of surgery. Aortopulmonary and venovenous collaterals are also well seen on CTA. viii. cMRI: It provides the same information as CTA, without exposing the child to radiation. However, cMRI facility is less commonly available and this test takes longer, sometimes necessitating the use of general anesthesia. It is useful in older children and adults who have undergone Fontan operation as MRI is the gold standard for assessing ventricular volumes and function in a univentricular heart. ix. Other tests: In those having heterotaxy syndrome, an abdominal ultrasound for situs and polysplenia/ asplenia is warranted. A peripheral blood smear for Howell-Jolly bodies should also be done.
Timing and type of intervention
Preamble Surgery for univentricular heart is a palliative procedure. The life expectancy is less than normal (exact age cannot be predicted) and is interposed by interventions over these years. [63] Treating physicians must inform and discuss the details with the parent/guardian before surgery.
The timing and type of intervention depends on age at presentation and presence or absence of obstruction to pulmonary blood flow. • Type of surgery: Systemic-to-pulmonary artery shunt or stenting of ductus arteriosus (depends on institutional policy and clinical scenario).
• Indications of surgery:
• When systemic arterial saturation is consistently below 70%-75%.
• I n c a s e o f p u l m o n a r y a t r e s i a w i t h duct-dependent pulmonary circulation (baby is usually on prostaglandin infusion). 
Important determinants of long-term prognosis
The interventions for a univentricular heart are always palliative, and these patients experience a number of morbidities on long term. These include development of ventricular dysfunction, growth failure, worsening cyanosis, arrhythmias, AV valve regurgitation, thrombosis and thromboembolic events, protein-losing enteropathy, plastic bronchitis, hepatic dysfunction, and chronic Fontan failure.
Recommendations for follow-up
i. All patients with univentricular heart (operated or unoperated) require lifelong follow-up. Frequency should be individualized, but should be at least once a year in stable cases. ii. Follow-up after bidirectional Glenn procedure:
Clinical assessment, oxygen saturation, ECG, echocardiography, cardiac catheterization, and CTA in select cases to decide suitability and timing of total cavopulmonary connection. iii. Follow-up after total cavopulmonary connection:
Clinical assessment, oxygen saturation, ECG, X-ray chest, and echocardiography. In addition, hematological and kidney and liver function tests should be done. cMRI may be performed at least once in adult life and then repeated, if indicated. Periodic imaging of liver by ultrasound, and additional imaging by CT/MRI/biopsy, especially starting 10 years after total cavopulmonary connection. [66] iv. Drugs after surgery: Aspirin (3-5 mg/kg/day) for all patients. Oral anticoagulants (warfarin) and sildenafil in select group or as per institution policy. [67] v. The threshold for performing cardiac catheterization during follow-up should be low as a number of complications can be successfully treated if diagnosed in time. vi. IE prophylaxis is recommended in patients with cyanosis and in cases with conduits or other prosthetic materials in the heart. However, all patients with univentricular heart are advised to maintain good oro-dental hygiene.
PERSISTENT TRUNCUS ARTERIOSUS
Background Persistent truncus arteriosus is characterized by a single arterial vessel that arises from the base of the heart and gives origin to the coronary, pulmonary, and systemic arteries. It accounts for < 1% of all congenital heart defects with a prevalence rate of 0.07/1000 live births. [46] There is associated microdeletion of chromosome 22q11.2 in about 40% of patients. [68] The aortic arch is right sided in about one-third of patients. [69, 70] Aortic arch interruption or coarctation of the aorta is found in 15%-20% of patients with truncus arteriosus. [71] Physiologic consequences of truncus Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 arteriosus depend on the size of the pulmonary arteries and on the PVR, with truncal valve regurgitation/ stenosis adding to the hemodynamic burden on the ventricles. Patients usually present in the first few weeks of life due to congestive heart failure and failure to thrive. Untreated patients have a very high mortality, mainly due to congestive heart failure, with a survival rate of 35% at 6 months and 10% at 1 year. [71] Classification of truncus arteriosus [72] i. Type A1 -Aorta and main pulmonary artery originate from a single large common trunk. ii. Type A2 -Both pulmonary arteries arise separately and directly from the truncus. iii. Type A3 -One pulmonary artery arises from the truncus and the other is supplied by the PDA or collaterals from the aorta. iv. Type A4 -There is an associated obstructive lesion of the aortic arch.
Diagnostic workup
i. Clinical assessment: Little or no cyanosis with bounding pulses in early infancy. ii. Pulse oximetry: For quantifying cyanosis which may
give an estimate of PVR. iii. X-ray chest: It shows cardiomegaly and increased pulmonary vascular markings. A combination of a right aortic arch and increased pulmonary vascularity is strongly suggestive of truncus arteriosus. A dilated truncal root resembles a dilated ascending aorta. Main pulmonary artery segment may arise at a higher level (Type A1) or may be absent (when pulmonary arteries arise directly from truncus). iv. ECG: There is usually a normal QRS axis or minimal right-axis deviation and combined ventricular hypertrophy and left atrial enlargement. When pulmonary blood flow is reduced due to increase in PVR, there is right-axis deviation and predominant right ventricular hypertrophy. v. Echocardiography: It is the key tool for the diagnosis and assessment of anatomy, location of VSD, presence and severity of truncal valve regurgitation or stenosis, and for associated lesions such as aortic arch interruption and coronary artery anomalies. vi. CTA/cMRI: They are useful in select cases when the anatomy is unclear on echocardiography, especially for the evaluation of aortic arch. These tests are recommended for follow-up imaging after surgical intervention. vii. Cardiac catheterization: Indicated in older patients beyond infancy with suspected pulmonary vascular disease, for the assessment of operability. viii. Serum calcium levels and genetic testing for microdeletion of chromosome 22q11.2 when clinically indicated.
Ideal age for surgery Surgery indicated in all, unless the patient is inoperable. i. Uncontrolled heart failure: Surgical repair as soon as possible (Class I). ii. Controlled heart failure: Surgical repair by 3-6 weeks of age (Class I). iii. Bilateral pulmonary artery banding reserved for complex cases and patients with contraindications for cardiopulmonary bypass (Class IIb).
Type of surgery
Total repair using RV-to-pulmonary artery conduit. Nonconduit options (Barbero-Marcial technique) may be possible in select cases. The prospects of repeat surgeries in future for conduit obstruction should be discussed with parents. Truncal valve repair is done if truncal valve is regurgitant.
Contraindication for surgery
Severe pulmonary arterial hypertension with irreversible pulmonary vascular occlusive disease (Class III). Signs of inoperability include age >1 year, resting systemic arterial saturation <85%, and absence of cardiomegaly.
Patients with borderline operability due to pulmonary vascular disease should be referred to a higher center for further evaluation. The decision to operate or not should be made on an individual basis taking into account the history, examination, and results of all the investigations.
Important determinants of long-term prognosis
These include residual or progressive pulmonary hypertension, need for conduit replacement, progressive truncal/neoaortic valve regurgitation, aortic root dilatation/aneurysm, and recurrent arch obstruction in Type A4.
Recommendations for follow-up after surgery
i. Lifelong follow-up is required in view of above-listed postoperative issues. ii. Follow-up after surgery with clinical assessment, X-ray chest, ECG, and echocardiography at 1, 6, and 12 months and yearly thereafter in stable cases. iii. IE prophylaxis is recommended after surgical repair due to the presence of conduit. All patients are advised to maintain good oro-dental hygiene.
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION
Background TAPVC occurs in 0.5-0.9/10,000 live births and accounts for 1% of all patients born with congenital heart defects. [11, 73] It has no specific sex predilection. An ASD is necessary for survival. TAPVC frequently occurs as an isolated lesion, but may be associated with other more complex CHDs such as heterotaxy syndrome with asplenia. TAPVC is classified into four Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 types depending on the site of drainage. [74] Each type can be obstructive or nonobstructive. The four types and their relative frequencies are: Supracardiac (45%-50%), cardiac (15%-20%), infracardiac (26%-28%), and mixed (where the drainage is at two or more sites, 5%-8%). [75] Obstruction to the drainage of pulmonary veins is most common in the infracardiac variety and least common in the cardiac type. If not treated, TAPVC has a very high mortality with 85% dying in the 1 st year of life. The median survival was 2 months (range 1 day to 49 years) in the article published by Hazelrig et al. [76] However, some of the exceptional survivors present later in life with clinical features suggestive of a large ASD, but have mild desaturation. Pulmonary venous obstruction significantly reduces median survival from 2.5 months in the nonobstructive group to 3 weeks in the obstructive group. [76] Obstructive TAPVC is the only cyanotic CHD where prostaglandin infusion should be avoided. 
Diagnostic workup
Important determinants of long-term prognosis
These include residual pulmonary vein stenosis, residual pulmonary hypertension, progressive stenosis of surgically created anastomosis, and late-onset arrhythmias. Pulmonary venous obstruction occurs in 5%-15% of patients after surgical repair.
Recommendations for follow-up
i. After surgery, patients should be followed up at 1 month, 6 months, and then annually for 5 years if there is no residual defect (including pulmonary vein obstruction). ii. ECG and echocardiography should be done at each visit. iii. CTA/cMRI should be done in operated patients suspected of having pulmonary venous obstruction iv. Because arrhythmias can occur long after TAPVC surgery, parents/patients should be informed to report if any symptom suggestive of arrhythmia develops beyond 5 years of follow-up. v. IE prophylaxis is indicated in noncorrected patients and in patients after surgical repair for 6 months. However, all patients with TAPVC are advised to maintain good oro-dental hygiene after this period also.
EBSTEIN'S ANOMALY OF THE TRICUSPID VALVE
Background
Ebstein's anomaly of the tricuspid valve is defined as failure of delamination of tricuspid leaflets from the myocardium. Mostly, the septal and the posterior leaflets are involved, and the anterior leaflet remains mobile. This results in the apical displacement of the functional tricuspid annulus and a rotation toward the outflow tract. A part of the RV inflow gets "atrialized." Tricuspid regurgitation of varying degree is invariably present, and the right atrium is enlarged. Some of the patients may be cyanosed due to right-to-left shunting at the atrial level. Ebstein's anomaly is rare, seen in 1 in 20,000 live births, and forms <1% of all congenital heart defects. [6] Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019
Associated lesions include accessory AV conduction pathways (15%-20%), and an interatrial communication is present in 80%-94% of cases. [77] Patients usually present either in neonatal period or during adolescence or adult life. Neonates may present with cyanosis and heart failure and at times with functional pulmonary atresia with duct-dependent pulmonary circulation. Older patients present with murmur, arrhythmias, or cyanosis. The estimated survival is 76% at 10 years and 53% at 15 years. [78] Prognosis is poor in those diagnosed during fetal or neonatal life. A number of classifications have been described for Ebstein's anomaly; the most commonly used classification was described by Carpentier et al. in 1988. [79] Diagnostic workup 
Important determinants of long-term prognosis
These include recurrence of tricuspid valve regurgitation with need for reoperation, right ventricular dilatation and dysfunction, supraventricular and ventricular tachyarrhythmias, and need for pacemaker implantation.
Recommendations for follow-up
i. Lifelong follow-up is required for all patients with Ebstein's anomaly. ii. ECG, X-ray chest, and echocardiography should be done at each visit. Holter, exercise testing, and cMRI may be required in select patients. iii. Asymptomatic patients who are not candidates for surgery can be followed up every 2-3 years. iv. Posttricuspid valve repair patients should be followed up every 2-3 years if there is no, trivial or mild tricuspid regurgitation and no other residual defect. ii. Angiotensin-converting enzyme inhibitors are indicated in patients with severe MR and severe AR. These drugs are usually required over short term before surgery, but may be used long term in patients with symptoms or left ventricular dysfunction who are not candidates for valve surgery and in asymptomatic patients with normal left ventricular systolic function to extend the compensated phase before the need for valve surgery. iii. Diuretics to be used in those with dyspnea due to heart failure. iv. Sodium nitroprusside infusion is recommended for the treatment of acute MR; invasive BP monitoring is required for these cases. v. Anticoagulants (oral) if atrial fibrillation is present. vi. Secondary prophylaxis, preferably with long-acting benzathine penicillin injection, is required for patients who have underlying rheumatic heart disease as the etiology of MR or AR.
Indications and timing of surgery
Mitral regurgitation [80, 81] i. Symptomatic patients with moderate-to-severe MR with left ventricular ejection fraction >30% (Class I). Aortic regurgitation [80] i. Symptomatic patients with moderate-to-severe AR (Class I). ii. Asymptomatic patients with severe AR: Surgery indicated if any of the following present (Class I): a. Left ventricular ejection fraction <50%. b. Left ventricular end-systolic dimension Z score >4. iii. Asymptomatic patients with moderate or severe AR undergoing cardiac surgery for another indication (Class I).
All patients with valvular regurgitation must be advised to maintain good oro-dental hygiene.
Type of valve surgery [82] i. V a l v e r e p a i r s a r e p r e f e r a b l e t o v a l v e replacements (Class I). Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019
ii. Valve replacement in those in whom valve cannot be repaired (Class IIa). a. Ross procedure for young patients with nonrheumatic AR (if expertise available). b. Bioprosthetic valve for:
• Female patients planning pregnancy in future.
•
Compliance with oral anticoagulation is dubious.
c. Prosthetic metallic valve replacements for the rest of patients.
Anticoagulation after valve surgery [83] i. Follow-up as for native valve regurgitation. v. IE prophylaxis: [83] All patients must be advised to maintain good oro-dental hygiene after valve surgery. Prophylaxis is reasonable before dental procedures that involve manipulation of gingival tissue, manipulation of the periapical region of teeth, or perforation of the oral mucosa in patients with the following (Class IIa): a. Prosthetic heart valves b. Prosthetic material used for cardiac valve repair, such as annuloplasty rings and chords c. Previous IE
CARDIAC PACEMAKERS IN CHILDREN
Background
The scope and clinical indications of implanting pacemaker and other devices have increased with the current generation of devices being small in size, having a longer battery life, advanced programming capabilities, and ability to treat arrhythmias as well as heart failure. The pacing lead can be put either through a transvenous route (subclavian or axillary vein) or directly over the heart (epicardial pacing). Transvenous pacemaker implantation is preferred approach; however, in specific conditions, epicardial pacemaker is implanted.
Indications of permanent pacemaker implantation [84] Class I indications i. Symptomatic patients with advanced second/ third-degree AV conduction block ii. Symptomatic patients with sinus node dysfunction and bradycardia with correlation of symptoms iii. Postoperative advanced second/third-degree AV conduction block that is not expected to resolve or lasting 10 days after cardiac surgery iv. Asymptomatic congenital third-degree AV block (CHB) with a. Class IIa indications i. Patients with CHD and sinus bradycardia for the prevention of recurrent episodes of intra-atrial reentrant tachycardia ii. Sinus bradycardia with complex CHD with resting HR <40 bpm or pauses in ventricular rate longer than 3 s iii. CHD and impaired hemodynamics due to sinus bradycardia or loss of AV synchrony iv. U n e x p l a i n e d s y n c o p e i n a p a t i e n t w i t h prior congenital heart surgery complicated by transient CHB with residual fascicular block, after a careful evaluation to exclude other causes of syncope Epicardial pacemaker is used instead of transvenous endocardial pacemaker in the following circumstances [85] i. Weight <10-15 kg ii. Congenital heart defects, repaired or unrepaired, with right-to-left shunt iii. Venous abnormality or congenital malformations which make a venous lead implantation impossible, is superior to ventricular pacing as it maintains AV synchrony. However, in small children, single-chamber pacing is acceptable.
• In patients undergoing epicardial pacemaker implantation, left ventricular (or systemic ventricle) pacing is superior to right ventricular pacing.
Other important considerations for cardiac pacing in children
i. In general, permanent pacemakers are required for life and repeated procedures are necessary to change pacemaker generator and/or pacing leads. The available pacemakers usually have a battery life of 5-10 years depending on the usage. ii. The procedure should be carried out by experienced operator. iii. Site of implantation and venous access should be conserved as much as possible. iv. During transvenous pacing, an additional loop of pacing lead should be left in right atrium in children to allow continued pacing with somatic growth of the child.
Complications of cardiac pacing in children
A number of complications secondary to permanent pacemaker have been described; however, some are more likely to occur in children. These include: i. Lead failure: More frequently seen in children, resulting in inappropriate sensing or capture. ii. Infection of the pacemaker system is a serious complication and almost always necessitates complete system removal. iii. Vascular complications: Significant vascular access challenges can also be due to previous cardiac surgical procedures. iv. Decreased ventricular function secondary to chronic right ventricular pacing over long periods. v. Others: Pneumothorax, endocarditis/pericarditis, hematoma, atrial or ventricular perforation.
Recommendations for follow-up after implantation of a pacemaker
i. Patient to be assessed at the time of discharge, 1-2 weeks, 3 months, and then 6 monthly. ii. Follow-up should include clinical assessment, including the health of the local site of implantation, ECG, device Annals of Pediatric Cardiology / Volume XX / Issue XX / Month 2019 interrogation for pacing threshold and battery life, and echocardiography (especially in children with CHD). iii. X-ray chest should be done annually. iv. Holter in select cases if indicated.
